Stay updated with breaking news from Diagnostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lucid Diagnostics (NASDAQ:LUCD – Get Rating) had its price objective lowered by Cantor Fitzgerald from $4.50 to $4.00 in a research note published on Wednesday, The Fly reports. Separately, Needham & Company LLC restated a buy rating and set a $2.60 target price on shares of Lucid Diagnostics in a report on Friday, April 21st. […]
StockNews.com initiated coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Get Rating) in a report released on Thursday morning. The brokerage issued a sell rating on the medical research company’s stock. Accelerate Diagnostics Trading Up 1.1 % Shares of Accelerate Diagnostics stock opened at $0.74 on Thursday. The firm has a market cap of $74.16 […]
StockNews.com started coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Get Rating) in a report issued on Thursday. The brokerage issued a sell rating on the medical research company’s stock. Accelerate Diagnostics Stock Performance AXDX stock opened at $0.74 on Thursday. The business has a fifty day simple moving average of $0.68 and a 200-day […]
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) – Stock analysts at HC Wainwright boosted their Q2 2023 earnings estimates for shares of Co-Diagnostics in a report issued on Monday, May 15th. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings per share of ($0.24) for the quarter, up from their prior forecast […]
Lucid Diagnostics (NASDAQ:LUCD – Get Rating) had its price target trimmed by Cantor Fitzgerald from $4.50 to $4.00 in a report issued on Wednesday, The Fly reports. Separately, Needham & Company LLC restated a buy rating and issued a $2.60 price objective on shares of Lucid Diagnostics in a report on Friday, April 21st. Lucid […]